review Open AccessTop 1% cited
Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013
European Radiology · 2015 · Vol. 25(12) · pp. 3438–3454
A. Gillams✉(London Clinic)Nahum Goldberg(Beth Israel Deaconess Medical Center)Muneeb Ahmed(Beth Israel Deaconess Medical Center)Reto Bale(University Hospital Innsbruck)David J. Breen(University Hospital Southampton NHS Foundation Trust)Matthew R. Callstrom(Mayo Clinic)Minhua Chen(Peking University)Byung Ihn ChoiThierry de Baère(Institut Gustave Roussy)Damian E. Dupuy(Rhode Island Department of Health)Afshin Gangi(Université de Strasbourg)Debra A. Gervais(Harvard University Press)Thomas Helmberger(München Klinik Bogenhausen)Ernst-Michael Jung(University of Regensburg)Fred Lee(University of Wisconsin–Madison)Riccardo Lencioni(University of Pisa)Ping Liang(Chinese PLA General Hospital)Tito Livraghi(Humanitas University)David Lu(University of California, Los Angeles)Maria Franca Meloni(University of Milan)Philippe L. Pereira(Heidelberg University)Fabio Piscaglia(University of Bologna)Hyunchul Rhim(Sungkyunkwan University)Riad Salem(Northwestern University)Constantinos T. Sofocleous(Memorial Sloan Kettering Cancer Center)Stephen B. Solomon(Memorial Sloan Kettering Cancer Center)Michael C. Soulen(California University of Pennsylvania)Masatoshi Tanaka(ShinKokura Hospital)Thomas J. Vogl(Goethe University Frankfurt)Bradford J. Wood(National Institutes of Health)Luigi Solbiati(Ospedale di Circolo di Busto Arsizio)
Abstract
• Best results require due consideration of tumour size, number, volume and location. • Ablation technology, imaging guidance and intra-procedural imaging assessment must be optimised. • Accepted applications include inoperable disease due to tumour distribution or inadequate liver reserve. • Other current indications include concurrent co-morbidity, patient choice and the test-of-time approach. • Future applications may include resectable disease, e.g. for small solitary tumours.
Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesCholangiocarcinoma and Gallbladder Cancer StudiesMedicineInterventional radiologyAblationRadiofrequency ablationRandomized controlled trialColorectal cancerRadiologyThermal ablationMedical physicsClinical trial
MeSH terms
HumansLiver NeoplasmsColorectal NeoplasmsSurvival AnalysisAblation Techniques
Funding
- Boston Scientific Corporation
- Samsung
Citations
314
FWCI
13.41
field-weighted impact
References
90
Percentile
99%
vs. same field & year
Citations per year
References
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
Annals of Surgery · 2004 · 1,748 citations
Complications of radiofrequency coagulation of liver tumours
British journal of surgery · 2002 · 683 citations
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases
Annals of Surgery · 2002 · 1,459 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
